522 related articles for article (PubMed ID: 17201718)
1. Direct and indirect costs of refractory epilepsy in a tertiary epilepsy center in Germany.
Hamer HM; Spottke A; Aletsee C; Knake S; Reis J; Strzelczyk A; Oertel WH; Rosenow F; Dodel R
Epilepsia; 2006 Dec; 47(12):2165-72. PubMed ID: 17201718
[TBL] [Abstract][Full Text] [Related]
2. Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany.
Strzelczyk A; Haag A; Reese JP; Nickolay T; Oertel WH; Dodel R; Knake S; Rosenow F; Hamer HM
Epilepsy Behav; 2013 Jun; 27(3):433-8. PubMed ID: 23591262
[TBL] [Abstract][Full Text] [Related]
3. Direct and indirect costs associated with epileptic partial onset seizures among the privately insured in the United States.
Ivanova JI; Birnbaum HG; Kidolezi Y; Qiu Y; Mallett D; Caleo S
Epilepsia; 2010 May; 51(5):838-44. PubMed ID: 20002150
[TBL] [Abstract][Full Text] [Related]
4. Estimating the cost of epilepsy in Europe: a review with economic modeling.
Pugliatti M; Beghi E; Forsgren L; Ekman M; Sobocki P
Epilepsia; 2007 Dec; 48(12):2224-33. PubMed ID: 18088267
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of health-care utilization among adult patients with epilepsy in Germany.
Strzelczyk A; Nickolay T; Bauer S; Haag A; Knake S; Oertel WH; Reif PS; Rosenow F; Reese JP; Dodel R; Hamer HM
Epilepsy Behav; 2012 Apr; 23(4):451-7. PubMed ID: 22381385
[TBL] [Abstract][Full Text] [Related]
6. [Cost-effectiveness of epilepsy surgery in a cohort of patients with medically intractable partial epilepsy--preliminary results].
Picot MC; Neveu D; Kahane P; Crespel A; Gélisse P; Hirsch E; Derambure P; Dupont S; Landré E; Chassoux F; Valton L; Vignal JP; Marchal C; Rougier A; Lamy C; Semah F; Biraben A; Arzimanoglou A; Petit J; Thomas P; Dujols P; Ryvlin P
Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S354-67. PubMed ID: 15331984
[TBL] [Abstract][Full Text] [Related]
7. [Cost measurement based on a cost diary in patients with inflammatory bowel disease].
Rösch M; Leidl R; Tirpitz Cv; Reinshagen M; Adler G; König HH
Z Gastroenterol; 2002 Apr; 40(4):217-28. PubMed ID: 11961730
[TBL] [Abstract][Full Text] [Related]
8. Direct medical cost of children and adolescents epilepsy at a university setting in Croatia.
Prpić I; Boban M; Skarpa-Prpić I; Jurjević A; Babić T; Fiket D
Coll Antropol; 2009 Jun; 33(2):503-8. PubMed ID: 19662770
[TBL] [Abstract][Full Text] [Related]
9. Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany from 2003 to 2013 - A ten-year overview.
Willems LM; Richter S; Watermann N; Bauer S; Klein KM; Reese JP; Schöffski O; Hamer HM; Knake S; Rosenow F; Strzelczyk A
Epilepsy Behav; 2018 Jun; 83():28-35. PubMed ID: 29649671
[TBL] [Abstract][Full Text] [Related]
10. Economic burden of epilepsy in a developing country: a retrospective cost analysis in China.
Hong Z; Qu B; Wu XT; Yang TH; Zhang Q; Zhou D
Epilepsia; 2009 Oct; 50(10):2192-8. PubMed ID: 19583782
[TBL] [Abstract][Full Text] [Related]
11. Direct medical costs for partial refractory epilepsy in Mexico.
García-Contreras F; Constantino-Casas P; Castro-Ríos A; Nevárez-Sida A; Estrada Correa Gdel C; Carlos Rivera F; Guzmán-Caniupan J; Torres-Arreola Ldel P; Contreras-Hernández I; Mould-Quevedo J; Garduño-Espinosa J
Arch Med Res; 2006 Apr; 37(3):376-83. PubMed ID: 16513488
[TBL] [Abstract][Full Text] [Related]
12. Direct costs for the treatment of HIV-infection in a German cohort after the introduction of HAART.
Stoll M; Claes C; Schulte E; Graf von der Schulenburg JM; Schmidt RE
Eur J Med Res; 2002 Nov; 7(11):463-71. PubMed ID: 12568973
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population.
Davis KL; Candrilli SD; Edin HM
Epilepsia; 2008 Mar; 49(3):446-54. PubMed ID: 18031549
[TBL] [Abstract][Full Text] [Related]
14. Direct and indirect costs attributable to osteoarthritis in active subjects.
Rabenda V; Manette C; Lemmens R; Mariani AM; Struvay N; Reginster JY
J Rheumatol; 2006 Jun; 33(6):1152-8. PubMed ID: 16755664
[TBL] [Abstract][Full Text] [Related]
15. Annual direct and indirect health care costs of chronic idiopathic urticaria: a cost analysis of 50 nonimmunosuppressed patients.
Delong LK; Culler SD; Saini SS; Beck LA; Chen SC
Arch Dermatol; 2008 Jan; 144(1):35-9. PubMed ID: 18209166
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and cost of nonadherence to antiepileptic drugs in elderly patients with epilepsy.
Ettinger AB; Manjunath R; Candrilli SD; Davis KL
Epilepsy Behav; 2009 Feb; 14(2):324-9. PubMed ID: 19028602
[TBL] [Abstract][Full Text] [Related]
17. Childhood epilepsy: a critical review of cost-of-illness studies.
Argumosa A; Herranz JL
Epileptic Disord; 2004 Mar; 6(1):31-40. PubMed ID: 15075066
[TBL] [Abstract][Full Text] [Related]
18. [Juvenile obesity and comorbidity type 2 diabetes mellitus (T2 DM) in Germany: development and cost-of-illness analysis].
Wolfenstetter SB
Gesundheitswesen; 2006 Oct; 68(10):600-12. PubMed ID: 17099820
[TBL] [Abstract][Full Text] [Related]
19. [Economic costs of childhood epilepsy in Spain].
Argumosa A; Herranz JL
Rev Neurol; 2000 Jan 16-31; 30(2):104-8. PubMed ID: 10730313
[TBL] [Abstract][Full Text] [Related]
20. Costs of epilepsy and cost-driving factors in children, adolescents, and their caregivers in Germany.
Riechmann J; Strzelczyk A; Reese JP; Boor R; Stephani U; Langner C; Neubauer BA; Oberman B; Philippi H; Rochel M; Seeger J; Seipelt P; Oertel WH; Dodel R; Rosenow F; Hamer HM;
Epilepsia; 2015 Sep; 56(9):1388-97. PubMed ID: 26235849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
